吸入肺薬物送達デバイスの世界市場成長 2024-2030Global Inhalation Pulmonary Drug Delivery Devices Market Growth 2024-2030 吸入肺薬物送達装置は、喘息、慢性閉塞性肺疾患(COPD)、その他の肺疾患などの呼吸器疾患の治療のために、肺に直接薬物を送達するように設計された特殊な医療機器である。これらの器具には、吸入器、ネブライザ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー吸入肺薬物送達装置は、喘息、慢性閉塞性肺疾患(COPD)、その他の肺疾患などの呼吸器疾患の治療のために、肺に直接薬物を送達するように設計された特殊な医療機器である。これらの器具には、吸入器、ネブライザー、ドライパウダー吸入器などがあり、それぞれ薬剤を効率よく吸入できるようにエアロゾル化する異なるメカニズムを採用している。薬剤を肺の作用部位に直接送達することで、これらの機器は迅速な緩和を提供し、薬剤の有効性を向上させ、全身的な副作用を最小限に抑える。呼吸療法において不可欠なツールであり、患者に便利で効果的な症状管理手段を提供する。吸入肺薬物送達デバイスの世界市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は%であると予測されている。 LPインフォメーション株式会社(東京都港区、代表取締役:劉克振)の最新リサーチレポート「吸入肺薬物送達デバイス産業予測」は、2023年の吸入肺薬物送達デバイスの世界総売上高を過去の売上高から検証し、2024年から2030年までの吸入肺薬物送達デバイス売上高予測について地域別、市場分野別に包括的な分析を提供しています。吸入肺薬物送達デバイスの売上を地域別、市場セクター別、サブセクター別に分類し、世界の吸入肺薬物送達デバイス産業の詳細な分析を百万米ドル単位で提供します。 本インサイトレポートは、世界の吸入肺薬物送達デバイスの状況を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また本レポートでは、吸入肺薬物送達デバイスのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てた主要グローバル企業の戦略を分析し、加速する世界の吸入肺薬物送達デバイス市場におけるこれらの企業の独自の地位をより深く理解しています。 この調査レポートは、吸入肺薬物送達デバイスの世界的な展望を形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い方法論により、この調査予測は世界の吸入肺薬物送達デバイスの現状と将来の軌道について非常にニュアンスのある見解を提供します。 吸入肺薬物送達デバイスの米国市場は、2023年の100万米ドルから2030年までに100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 吸入肺薬物送達デバイスの中国市場は、2023年の百万米ドルから2030年には百万米ドルに、2024年から2030年までの年平均成長率は%と推定される。 吸入肺薬物送達デバイスのヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに、2024年から2030年までの年平均成長率は%と推定される。 吸入肺薬物送達デバイスの世界的な主要企業は、グラクソ・スミスクライン(GSK)、アストラゼネカ、ベーリンガーインゲルハイム、マイラン、ヴィアトリスなどである。売上高では、世界の2大企業が2023年にほぼ%のシェアを占めている。 のシェアを占めている。 当レポートでは、吸入肺薬物送達デバイス市場の包括的な概要、市場シェア、成長機会を、製品タイプ、用途、主要メーカー、主要地域、国別に紹介しています。 タイプ別セグメント 定量吸入器 乾燥粉末吸入器 ネブライザー 用途別セグメント 喘息 慢性閉塞性肺疾患(COPD) 嚢胞性線維症(CF) 特発性肺線維症(IPF) その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されている。 グラクソ・スミスクライン(GSK) アストラゼネカ ベーリンガーインゲルハイム マイラン ヴィアトリス ノバルティス アプターグループ キエシ・ファルマチェウティチ フィリップス テバ・ファーマシューティカル・インダストリーズ モナハン・メディカル オムロン PARIインターナショナル ベクチュラ H&Tプレスパート 本レポートで扱う主な質問 世界の吸入肺薬物送達デバイス市場の10年展望は? 吸入肺薬物送達デバイスの世界および地域別市場成長を促進する要因は何か? 市場別、地域別に最も急成長する技術は何か? 吸入肺薬物送達デバイスの市場機会は最終市場規模によってどのように異なるのか? 吸入肺薬物送達デバイスのタイプ別、用途別内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Inhalation Pulmonary Drug Delivery Devices by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Inhalation Pulmonary Drug Delivery Devices by Country/Region, 2019, 2023 & 2030 2.2 Inhalation Pulmonary Drug Delivery Devices Segment by Type 2.2.1 Metered- dose Inhalers 2.2.2 Dry-powder Inhalers 2.2.3 Nebulizers 2.3 Inhalation Pulmonary Drug Delivery Devices Sales by Type 2.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2019-2024) 2.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2019-2024) 2.3.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Type (2019-2024) 2.4 Inhalation Pulmonary Drug Delivery Devices Segment by Application 2.4.1 Asthma 2.4.2 Chronic Obstructive Pulmonary Disease (COPD) 2.4.3 Cystic Fibrosis (CF) 2.4.4 Idiopathic Pulmonary Fibrosis (IPF) 2.4.5 Others 2.5 Inhalation Pulmonary Drug Delivery Devices Sales by Application 2.5.1 Global Inhalation Pulmonary Drug Delivery Devices Sale Market Share by Application (2019-2024) 2.5.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue and Market Share by Application (2019-2024) 2.5.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Inhalation Pulmonary Drug Delivery Devices Breakdown Data by Company 3.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Company (2019-2024) 3.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Company (2019-2024) 3.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Company (2019-2024) 3.2.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Company (2019-2024) 3.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Company (2019-2024) 3.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Company 3.4 Key Manufacturers Inhalation Pulmonary Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Inhalation Pulmonary Drug Delivery Devices Product Location Distribution 3.4.2 Players Inhalation Pulmonary Drug Delivery Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Inhalation Pulmonary Drug Delivery Devices by Geographic Region 4.1 World Historic Inhalation Pulmonary Drug Delivery Devices Market Size by Geographic Region (2019-2024) 4.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Inhalation Pulmonary Drug Delivery Devices Market Size by Country/Region (2019-2024) 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Country/Region (2019-2024) 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Country/Region (2019-2024) 4.3 Americas Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.4 APAC Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.5 Europe Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.6 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Growth 5 Americas 5.1 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Country 5.1.1 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 5.1.2 Americas Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 5.2 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 5.3 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Region 6.1.1 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Region (2019-2024) 6.1.2 APAC Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2019-2024) 6.2 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 6.3 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Inhalation Pulmonary Drug Delivery Devices by Country 7.1.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 7.1.2 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 7.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 7.3 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices by Country 8.1.1 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 8.1.2 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 8.2 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 8.3 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Inhalation Pulmonary Drug Delivery Devices 10.3 Manufacturing Process Analysis of Inhalation Pulmonary Drug Delivery Devices 10.4 Industry Chain Structure of Inhalation Pulmonary Drug Delivery Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Inhalation Pulmonary Drug Delivery Devices Distributors 11.3 Inhalation Pulmonary Drug Delivery Devices Customer 12 World Forecast Review for Inhalation Pulmonary Drug Delivery Devices by Geographic Region 12.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Region 12.1.1 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Region (2025-2030) 12.1.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Type (2025-2030) 12.7 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 GlaxoSmithKline (GSK) 13.1.1 GlaxoSmithKline (GSK) Company Information 13.1.2 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.1.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 GlaxoSmithKline (GSK) Main Business Overview 13.1.5 GlaxoSmithKline (GSK) Latest Developments 13.2 AstraZeneca 13.2.1 AstraZeneca Company Information 13.2.2 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.2.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AstraZeneca Main Business Overview 13.2.5 AstraZeneca Latest Developments 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Company Information 13.3.2 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.3.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Boehringer Ingelheim Main Business Overview 13.3.5 Boehringer Ingelheim Latest Developments 13.4 Mylan 13.4.1 Mylan Company Information 13.4.2 Mylan Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.4.3 Mylan Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Mylan Main Business Overview 13.4.5 Mylan Latest Developments 13.5 Viatris 13.5.1 Viatris Company Information 13.5.2 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.5.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Viatris Main Business Overview 13.5.5 Viatris Latest Developments 13.6 Novartis 13.6.1 Novartis Company Information 13.6.2 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.6.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Novartis Main Business Overview 13.6.5 Novartis Latest Developments 13.7 AptarGroup 13.7.1 AptarGroup Company Information 13.7.2 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.7.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 AptarGroup Main Business Overview 13.7.5 AptarGroup Latest Developments 13.8 Chiesi Farmaceutici 13.8.1 Chiesi Farmaceutici Company Information 13.8.2 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.8.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Chiesi Farmaceutici Main Business Overview 13.8.5 Chiesi Farmaceutici Latest Developments 13.9 Koninklijke Philips 13.9.1 Koninklijke Philips Company Information 13.9.2 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.9.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Koninklijke Philips Main Business Overview 13.9.5 Koninklijke Philips Latest Developments 13.10 Teva Pharmaceutical Industries 13.10.1 Teva Pharmaceutical Industries Company Information 13.10.2 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.10.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Teva Pharmaceutical Industries Main Business Overview 13.10.5 Teva Pharmaceutical Industries Latest Developments 13.11 Monaghan Medical 13.11.1 Monaghan Medical Company Information 13.11.2 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.11.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Monaghan Medical Main Business Overview 13.11.5 Monaghan Medical Latest Developments 13.12 OMRON 13.12.1 OMRON Company Information 13.12.2 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.12.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 OMRON Main Business Overview 13.12.5 OMRON Latest Developments 13.13 PARI International 13.13.1 PARI International Company Information 13.13.2 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.13.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 PARI International Main Business Overview 13.13.5 PARI International Latest Developments 13.14 Vectura 13.14.1 Vectura Company Information 13.14.2 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.14.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Vectura Main Business Overview 13.14.5 Vectura Latest Developments 13.15 H&T Presspart 13.15.1 H&T Presspart Company Information 13.15.2 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.15.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 H&T Presspart Main Business Overview 13.15.5 H&T Presspart Latest Developments 14 Research Findings and Conclusion
SummaryInhalation pulmonary drug delivery devices are specialized medical instruments designed to deliver medication directly to the lungs for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These devices include inhalers, nebulizers, and dry powder inhalers, each employing different mechanisms to aerosolize medication so it can be inhaled efficiently. By delivering drugs directly to the site of action in the lungs, these devices provide rapid relief, improve drug efficacy, and minimize systemic side effects. They are essential tools in respiratory therapy, offering patients convenient and effective means of managing their conditions. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Inhalation Pulmonary Drug Delivery Devices by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Inhalation Pulmonary Drug Delivery Devices by Country/Region, 2019, 2023 & 2030 2.2 Inhalation Pulmonary Drug Delivery Devices Segment by Type 2.2.1 Metered- dose Inhalers 2.2.2 Dry-powder Inhalers 2.2.3 Nebulizers 2.3 Inhalation Pulmonary Drug Delivery Devices Sales by Type 2.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2019-2024) 2.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2019-2024) 2.3.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Type (2019-2024) 2.4 Inhalation Pulmonary Drug Delivery Devices Segment by Application 2.4.1 Asthma 2.4.2 Chronic Obstructive Pulmonary Disease (COPD) 2.4.3 Cystic Fibrosis (CF) 2.4.4 Idiopathic Pulmonary Fibrosis (IPF) 2.4.5 Others 2.5 Inhalation Pulmonary Drug Delivery Devices Sales by Application 2.5.1 Global Inhalation Pulmonary Drug Delivery Devices Sale Market Share by Application (2019-2024) 2.5.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue and Market Share by Application (2019-2024) 2.5.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Inhalation Pulmonary Drug Delivery Devices Breakdown Data by Company 3.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Company (2019-2024) 3.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Company (2019-2024) 3.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Company (2019-2024) 3.2.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Company (2019-2024) 3.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Company (2019-2024) 3.3 Global Inhalation Pulmonary Drug Delivery Devices Sale Price by Company 3.4 Key Manufacturers Inhalation Pulmonary Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Inhalation Pulmonary Drug Delivery Devices Product Location Distribution 3.4.2 Players Inhalation Pulmonary Drug Delivery Devices Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Inhalation Pulmonary Drug Delivery Devices by Geographic Region 4.1 World Historic Inhalation Pulmonary Drug Delivery Devices Market Size by Geographic Region (2019-2024) 4.1.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Inhalation Pulmonary Drug Delivery Devices Market Size by Country/Region (2019-2024) 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Annual Sales by Country/Region (2019-2024) 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue by Country/Region (2019-2024) 4.3 Americas Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.4 APAC Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.5 Europe Inhalation Pulmonary Drug Delivery Devices Sales Growth 4.6 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales Growth 5 Americas 5.1 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Country 5.1.1 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 5.1.2 Americas Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 5.2 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 5.3 Americas Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Region 6.1.1 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Region (2019-2024) 6.1.2 APAC Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2019-2024) 6.2 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 6.3 APAC Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Inhalation Pulmonary Drug Delivery Devices by Country 7.1.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 7.1.2 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 7.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 7.3 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices by Country 8.1.1 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2019-2024) 8.1.2 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2019-2024) 8.2 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Type (2019-2024) 8.3 Middle East & Africa Inhalation Pulmonary Drug Delivery Devices Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Inhalation Pulmonary Drug Delivery Devices 10.3 Manufacturing Process Analysis of Inhalation Pulmonary Drug Delivery Devices 10.4 Industry Chain Structure of Inhalation Pulmonary Drug Delivery Devices 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Inhalation Pulmonary Drug Delivery Devices Distributors 11.3 Inhalation Pulmonary Drug Delivery Devices Customer 12 World Forecast Review for Inhalation Pulmonary Drug Delivery Devices by Geographic Region 12.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Region 12.1.1 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Region (2025-2030) 12.1.2 Global Inhalation Pulmonary Drug Delivery Devices Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Type (2025-2030) 12.7 Global Inhalation Pulmonary Drug Delivery Devices Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 GlaxoSmithKline (GSK) 13.1.1 GlaxoSmithKline (GSK) Company Information 13.1.2 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.1.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 GlaxoSmithKline (GSK) Main Business Overview 13.1.5 GlaxoSmithKline (GSK) Latest Developments 13.2 AstraZeneca 13.2.1 AstraZeneca Company Information 13.2.2 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.2.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AstraZeneca Main Business Overview 13.2.5 AstraZeneca Latest Developments 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Company Information 13.3.2 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.3.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Boehringer Ingelheim Main Business Overview 13.3.5 Boehringer Ingelheim Latest Developments 13.4 Mylan 13.4.1 Mylan Company Information 13.4.2 Mylan Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.4.3 Mylan Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Mylan Main Business Overview 13.4.5 Mylan Latest Developments 13.5 Viatris 13.5.1 Viatris Company Information 13.5.2 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.5.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Viatris Main Business Overview 13.5.5 Viatris Latest Developments 13.6 Novartis 13.6.1 Novartis Company Information 13.6.2 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.6.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Novartis Main Business Overview 13.6.5 Novartis Latest Developments 13.7 AptarGroup 13.7.1 AptarGroup Company Information 13.7.2 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.7.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 AptarGroup Main Business Overview 13.7.5 AptarGroup Latest Developments 13.8 Chiesi Farmaceutici 13.8.1 Chiesi Farmaceutici Company Information 13.8.2 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.8.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Chiesi Farmaceutici Main Business Overview 13.8.5 Chiesi Farmaceutici Latest Developments 13.9 Koninklijke Philips 13.9.1 Koninklijke Philips Company Information 13.9.2 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.9.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Koninklijke Philips Main Business Overview 13.9.5 Koninklijke Philips Latest Developments 13.10 Teva Pharmaceutical Industries 13.10.1 Teva Pharmaceutical Industries Company Information 13.10.2 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.10.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Teva Pharmaceutical Industries Main Business Overview 13.10.5 Teva Pharmaceutical Industries Latest Developments 13.11 Monaghan Medical 13.11.1 Monaghan Medical Company Information 13.11.2 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.11.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Monaghan Medical Main Business Overview 13.11.5 Monaghan Medical Latest Developments 13.12 OMRON 13.12.1 OMRON Company Information 13.12.2 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.12.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 OMRON Main Business Overview 13.12.5 OMRON Latest Developments 13.13 PARI International 13.13.1 PARI International Company Information 13.13.2 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.13.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 PARI International Main Business Overview 13.13.5 PARI International Latest Developments 13.14 Vectura 13.14.1 Vectura Company Information 13.14.2 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.14.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Vectura Main Business Overview 13.14.5 Vectura Latest Developments 13.15 H&T Presspart 13.15.1 H&T Presspart Company Information 13.15.2 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolios and Specifications 13.15.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 H&T Presspart Main Business Overview 13.15.5 H&T Presspart Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
LP Information 社の最新刊レポート本レポートと同じKEY WORD(drug delivery)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/06 10:26 144.24 円 160.68 円 192.83 円 |